This report highlights the successful treatment of a Charcot-Marie-Tooth disease case using the Regentime stem cell procedure, suggesting its potential as a promising therapeutic approach for patients suffering from this challenging condition.
Keywords: CMT; Charcot–Marie–Tooth disease; PMP22; Regentime procedure; autologous stem cell therapy; bone marrow mononuclear progenitor stem cells; neurodegenerative disease; neurological disorder; peripheral neuropathy; regenerative medicine.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.